Cancer Health Treatment Update First KRAS-Blocking Drug Approved for Advanced Lung Cancer Lumakras led to tumor shrinkage in 36% of NSCLC patients with KRAS G12C mutations. FDA Approves Targeted Therapy for Lung Cancer With EGFR Mutations Rybrevant is the first treatment for people with advanced non-small-cell lung cancer whose tumors have EGFR exon 20 insertion mutations. For Early-Stage Cervical Cancer, Minimally Invasive Surgery Declining More radical hysterectomies in women with early-stage cervical cancer are being performed by “open” surgery. Advertisement My Life With Metastatic Breast Cancer Deltra Kroemer, 35, lives in Waterbury, Connecticut, with her five children. She has Stage IV breast cancer. Top Cancer Centers Call for Action to Get HPV Vaccination Back on Track The COVID-19 pandemic has interrupted delivery of key health services for children and adolescents, including HPV vaccination for cancer prevention. More News About COVID-19 See all Cancer Health coverage of COVID-19, including how it affects people living with cancer. For more news about the SARS-CoV-2 coronavirus, visit our sister site, COVID Health.com. Cancer Health Spring 2021 Check out our latest print edition! Newsfeed Is Cancer a Mostly Modern Phenomenon? Maybe Not. Top Cancer Centers Call for Action to Get HPV Vaccination Back on Track From Insurance Claim Denials To Smiles, Payment And Feeling Empowered “45 Is The New 50” As Age For Colorectal Cancer Screening Is Lowered Blog: Food and Drug Administration (FDA) FDA Approves Keytruda for HER2-Positive Stomach Cancer FDA Authorizes First Device that Uses Artificial Intelligence to Help Detect Colon Cancer FDA Approves New Targeted Therapy for Lymphoma FDA Approves Immunotherapy for Endometrial Cancer with Specific Biomarker Newsfeed Is Cancer a Mostly Modern Phenomenon? Maybe Not. Top Cancer Centers Call for Action to Get HPV Vaccination Back on Track From Insurance Claim Denials To Smiles, Payment And Feeling Empowered “45 Is The New 50” As Age For Colorectal Cancer Screening Is Lowered Blog: Food and Drug Administration (FDA) FDA Approves Keytruda for HER2-Positive Stomach Cancer FDA Authorizes First Device that Uses Artificial Intelligence to Help Detect Colon Cancer FDA Approves New Targeted Therapy for Lymphoma FDA Approves Immunotherapy for Endometrial Cancer with Specific Biomarker

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: